Analysts offer 7 reasons why a Covid-19 vaccine could fail

In a new report, SVB Leerink analysts looked at where the market may be overeager as investors flock to vaccine stocks.

Source: bizjournals.com Health Care:Biotechnology headlines - September 23, 2020 Category: Biotechnology Authors: Allison DeAngelis Source Type: news